New cervical cancer screening guidelines: 3 key changes

Evan Walker
Evan Walker TheMediTary.Com |
silhouette of woman with long wavy hair blowing in the windShare on Pinterest
What do the new cervical cancer screening guidelines say? We outline three key changes. Image credit: Maria Korneeva/Getty Images
  • On December 4, the American Cancer Society (ACS) released updates to their cervical cancer screening guidelines.
  • The new guidelines call for people at average risk for cervical cancer to start screenings at age 25.
  • They now have the option to use a Food and Drug Administration (FDA)-approved self-collecting HPV kit.
  • ACS has updated the specifications on when a woman can stop cervical screenings by age 65.

According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among women worldwide, with about 660,000 new cases.

Studies project that cervical cancer numbers may jump by almost 57% by 2050.

A Pap test or Pap smear is a preventive test that can help diagnose early signs of cervical cancer. In many instances, your doctor may also co-test you for a sexually transmitted infection (STI) with the human papillomavirus (HPV) during a Pap smear.

This is because having certain variants of HPV may increase a woman’s risk for cervical cancer.

On December 4, 2025 the American Cancer Society (ACS) released updates to their cervical cancer screening guidelines with a few main changes, including an updated start age for screenings, a new HPV self-testing option, and additional guidelines for when a woman should stop having screenings.

The screening updates were also published in CA: A Cancer Journal for Clinicians, the flagship journal of the ACS.

Medical News Today spoke with four obstetrics and gynecology experts to find out more about what these guidelines changes are and what they mean cisgender female readers.

While the ACS still highly recommends women have HPV testing performed on a cervical sample collected by their doctor every 5 years, the new guidelines now allow women to collect their own HPV testing sample using a test approved by the Food and Drug Administration (FDA).

“A self-collected HPV test is a self sampling kit that can be used by a patient at home or in a clinic setting,” Blair R Gumnic, DO, an obstetrician/gynecologist (OB/GYN) at the Hackensack Meridian Jersey Shore University Medical Center in New Jersey, explained to MNT.

“It screens only for high risk HPV which is the virus that can cause cervical cancer. If you have a positive result from a self-collected test, you will still need to follow up with a doctor. A Pap smear is a test that can only be done by a medical provider that evaluates both cellular change of the cervix and the HPV virus,” Gumnic detailed.

“A gynecologic exam is the most common method to complete testing, regardless of which method is used,” added Jason Knight, MD, a board-certified gynecologic oncologist and regional director of Gynecologic Oncology at Atlantic Health.

“However,“ said Knight, “self-collected HPV testing is becoming increasingly available. While the self-collected test does not require a gynecologic exam, it does require a prescription for a sample collection kit, particularly if at-home sample collection is desired. The sample is collected privately by the individual themself using a collection swab or brush which is placed inside the vagina. The sample is then returned to the lab for processing.”

Another update to ACS’s guidelines is starting cervical cancer screenings at age 25 for those at average risk for cervical cancer, and should be performed every 3 to 5 years, depending on which test a person uses.

“Pap testing has been the cornerstone of early detection,” Knight explained. “In recent years, testing for HPV has been an option for some patients as an alternative to, or in combination with, Pap testing. Stand-alone HPV testing is now recognized as more powerful at identifying individuals requiring follow up (and in some cases, treatment) than the stand-alone Pap test.”

“As a result, the American Cancer Society has revised its cervical cancer screening guideline to recommend HPV testing, by itself, as the preferred method for cervical cancer screening in individuals with a cervix between the age of 25 and 65,” he continued. “Screening with the Pap test, by itself, or in combination with the HPV test, remain options recognized by the guideline.”

“Determining which method to use is best accomplished in consultation with your doctor,” Knight added. “The American Cancer Society recommends testing every 5 years for individuals who have medical-provider-collected HPV screening, by itself, or in combination with a Pap test. Testing is recommended every 3 years for individuals using the self-collected HPV test, or if a provider-collected Pap is not combined with an HPV test.”

The third main update to the ACS’s guidelines is more detailed information on when a to stop cervical cancer screenings.

“According to the guidelines, screening can stop after the age of 65 if a person has been consistently receiving screening every 3 to 5 years, according to the prevailing guideline at that time, and if the last three tests (if HPV testing was not included in screening) or if the last two tests (if HPV testing was included in screening) have been normal,” Knight detailed.

“It is possible to stop screening in this case because the likelihood of acquiring an HPV infection, and for that infection to persist long enough to cause cancer, is particularly low,” he added.

“The screening for cervical cancer does not need to continue indefinitely for women aged 65 and older, as long as their prior screening history meets the new criteria and there is no high-risk history,” Gumnic explained.

“Previous guidelines recommended stopping screening at age 65 if prior screenings were normal, however did not provide clear criteria for the definition of prior normal screenings. This new information provides a more definitive guideline for when cervical cancer screening can be stopped. This helps to reduce over screening while still keeping patients safe,” said the OB/GYN.

Share this Article